Search Results - "Gundacker, H M"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial by Gordon, M.A., Gundacker, H.M., Benedetti, J., Macdonald, J.S., Baranda, J.C., Levin, W.J., Blanke, C.D., Elatre, W., Weng, P., Zhou, J.Y., Lenz, H.J., Press, M.F.

    Published in Annals of oncology (01-07-2013)
    “…Trastuzumab has been approved for patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic gastric carcinoma; however, relatively…”
    Get full text
    Journal Article
  2. 2

    Within-Subject Variation in CD4 Lymphocyte Count in Asymptomatic Human Immunodeficiency Virus Infection: Implications for Patient Monitoring by Hughes, Michael D., Stein, Daniel S., Gundacker, Holly M., Valentine, Fred T., Phair, John P., Volberding, Paul A.

    Published in The Journal of infectious diseases (01-01-1994)
    “…Changes in CD4 lymphocyte counts are widely used in monitoring human immunodeficiency virus (HIV)-infected patients for disease progression. However, random…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial by Gordon, M A, Gundacker, H M, Benedetti, J, Macdonald, J S, Baranda, J C, Levin, W J, Blanke, C D, Elatre, W, Weng, P, Zhou, J Y, Lenz, H J, Press, M F

    Published in Annals of oncology (01-07-2013)
    “…Trastuzumab has been approved for patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic gastric carcinoma; however, relatively…”
    Get full text
    Journal Article
  5. 5